SPP1 and prostate carcinoma: Moreover, OPN is known as a biomarker for prostate cancer and for its role in tumour progression.51 The antibody against OPN detected recOPN at the concentrations of 50 and 16.6 ng and at a relative molecular weight of 70 kDa (Figure 1C).